OMNI SURGICAL SYSTEM
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $873,363 | 6,340 | 3,024 |
| 2023 | $878,946 | 3,318 | 1,924 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $695,160 | 276 | 39.7% |
| Food and Beverage | $512,397 | 9,171 | 29.2% |
| Unspecified | $341,720 | 56 | 19.5% |
| Consulting Fee | $100,791 | 34 | 5.8% |
| Grant | $65,000 | 7 | 3.7% |
| Travel and Lodging | $28,887 | 110 | 1.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,853 | 3 | 0.3% |
| Honoraria | $3,500 | 1 | 0.2% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| An Observational Multicenter Clinical Study to Assess the Long-term Safety and Effectiveness of the OMNI Surgical System in Combination with Cataract Surgery in Eyes with Open Angle Glaucoma (GEMINI 2.0) | Sight Sciences, Inc. | $136,790 | 3 |
| An Observational Multicenter Clinical Study to Assess the Safety and Effectiveness of the OMNI Surgical System in Pseudophakic Eyes with Primary Open Angle Glaucoma (ORION 2.0) | Sight Sciences, Inc. | $55,205 | 1 |
| Prospective Randomized Masked Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA) | Sight Sciences, Inc. | $50,000 | 0 |
| Real World Efficacy of Canaloplasty and Trabeculotomy For Treatment of Glaucoma | Sight Sciences, Inc. | $28,875 | 1 |
| A Single Center Case Series Comparison of Signs and Symptoms Pre- and Post-Tearcare Treatment | Sight Sciences, Inc. | $26,633 | 0 |
| Impact of TearCare on Reading Speed | Sight Sciences, Inc. | $18,947 | 0 |
| PRECISION | Sight Sciences, Inc. | $4,584 | 0 |
Top Doctors Receiving Payments for OMNI SURGICAL SYSTEM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Miami, FL | $282,987 | 50 |
| Arkadiy Yadgarov | Ophthalmology | Atlanta, GA | $64,102 | 57 |
| , M.D | Ophthalmology | Miami, FL | $50,296 | 58 |
| , MD | Ophthalmology | Norfolk, VA | $49,558 | 9 |
| , M.D | Ophthalmology | New York, NY | $46,807 | 38 |
| , MD | Ophthalmology | Indianapolis, IN | $45,224 | 11 |
| , M.D | Ophthalmology | Hamden, CT | $43,030 | 32 |
| , MD | Ophthalmology | Stanford, CA | $41,964 | 17 |
| , MD | Glaucoma Specialist | Dearborn, MI | $33,422 | 38 |
| , OD | Optometrist | Coldwater, MS | $32,455 | 34 |
| , MD | Ophthalmology | Reading, MA | $27,004 | 39 |
| , MD | Ophthalmology | Jenkintown, PA | $26,417 | 16 |
| , M.D | Ophthalmology | Woodland Park, NJ | $23,294 | 43 |
| , MD | Ophthalmology | Oklahoma City, OK | $21,662 | 4 |
| , MD | Ophthalmology | Petaluma, CA | $21,508 | 33 |
| , MD | Ophthalmology | West Lake Hills, TX | $20,510 | 21 |
| , MD | Ophthalmology | Williamsville, NY | $17,870 | 22 |
| , M.D | Student in an Organized Health Care Education/Training Program | Miami, FL | $16,509 | 21 |
| , M.D | Glaucoma Specialist | Chicago, IL | $15,576 | 14 |
| , M.D | Glaucoma Specialist | Fort Worth, TX | $14,575 | 5 |
| , MD | Ophthalmology | Staten Island, NY | $14,460 | 17 |
| , M.D | Ophthalmology | Miami, FL | $13,585 | 23 |
| , M.D | Ophthalmology | Columbia, SC | $12,478 | 24 |
| , MD | Ophthalmology | New Haven, CT | $12,173 | 15 |
| , MD | Ophthalmology | Bala Cynwyd, PA | $12,002 | 18 |
Manufacturing Companies
- Sight Sciences, Inc. $1.8M
Product Information
- Type Device
- Total Payments $1.8M
- Total Doctors 4,117
- Transactions 9,658
About OMNI SURGICAL SYSTEM
OMNI SURGICAL SYSTEM is a device associated with $1.8M in payments to 4,117 healthcare providers, recorded across 9,658 transactions in the CMS Open Payments database. The primary manufacturer is Sight Sciences, Inc..
Payment data is available from 2023 to 2024. In 2024, $873,363 was paid across 6,340 transactions to 3,024 doctors.
The most common payment nature for OMNI SURGICAL SYSTEM is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($695,160, 39.7% of total).
OMNI SURGICAL SYSTEM is associated with 7 research studies, including "An Observational Multicenter Clinical Study to Assess the Long-term Safety and Effectiveness of the OMNI Surgical System in Combination with Cataract Surgery in Eyes with Open Angle Glaucoma (GEMINI 2.0)" ($136,790).